Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Biohaven Pharmaceutical Holding Company Ltd (BHVN)

33.0075 0.557 (1.72%)

05-22 11:18

Open:

32.45

Pre. Close:

32.45

High:

33.245

Low:

32.45

Volume:

83,467

Market Cap:

1284M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

33.02 - 33.117

33.117 - 33.227

Low:

31.209 - 31.326

31.326 - 31.457

Close:

32.24 - 32.42

32.42 - 32.621

Technical analysis  (as of: 2018-05-22 11:07:51 AM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 38.83     One year: 45.35

Support:

Support1: 28.52    Support2: 25.60

Resistance:

Resistance1: 33.24    Resistance2: 38.83

Pivot:

29.04

Moving Averages:

MA(5): 31.34     MA(20): 28.84

MA(100): 28.97     MA(250): 28.46

MACD:

MACD(12,26): 1.16     Signal(12,26,9): 0.65

%K %D:

%K(14,3): 92.24     %D(3): 91.01

RSI:

RSI(14): 71.49

52-Week:

High: 39.509  Low: 16.5  Change(%): 50.0

Average Vol(K):

3-Month: 79155  10-Days 29637

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
BHVN has closed below upper band by 1.4%. Bollinger Bands are 14.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-05-17T00:16:34-04:00
Your Daily Pharma Scoop: Biohaven Updates, MEIP Offering, Kite European Expansions

2018-05-15T16:43:06-04:00
Biohaven Pharmaceuticals misses by $1.18

2018-05-15T16:35:23-04:00
Biohaven Pharma announces key milestones for 2018

2018-05-15T16:15:00-04:00
Biohaven Pharmaceuticals Reports First Quarter 2018 Financial and Recent Business Results

2018-05-14T12:27:31-04:00
Oryzon Genomics commences mid-stage study of Alzheimer's candidate

2018-05-10T02:04:51-04:00
Institutional Top Ideas Series: Ra Capital Management

2018-05-09T03:00:00-04:00
Biohaven Initiates Expanded Access Program for Sublingual BHV-0223 ZYDIS® Orally Dissolving Tablets for Patients with Amyotrophic Lateral Sclerosis (ALS)

2018-04-30T04:22:10-04:00
Allergan Hits Another Home Run For 2nd Migraine Study

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

38.61

Shares Float (M)

35.66

% Held by Insiders

7.60

% Held by Institutions

58.60

Shares Short (K)

2787

Shares Short Prior Month (K)

2050

Stock Financials

EPS

-5.460

EPS Est. Current Year

-5.450

EPS Est. Next Year

-4.390

EPS Est. Next Quarter

-1.110

Forward EPS

-4.227

Book Value (p.s.)

7.760

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-160.1

Return on Equity (ttm)

-637.5

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-2.552

Qtrly Earnings Growth

Operating Cash Flow (M)

-94.81

Levered Free Cash Flow (M)

-54.10

atoplab.com

Valuation

P/E

-6.00

P/E Growth Ratio

0.01

P/BV

4.22

P/S

P/CF

-13.34

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.